Recent studies have shown that intracellular Ca2' handling is abnormal in the myocardium of patients with end-stage heart failure. Muscles from the failing hearts showed a prolonged Ca2' transient and a diminished capacity to restore a low resting Ca2' level during diastole. Accordingly, we examined whether this defect in Ca2+ transport function is due to alterations in sarcoplasmic reticulum gene expression. We determined the messenger RNA (mRNA) levels of sarcoplasmic reticulum Ca21 transport proteins in failing human hearts from 17 cardiac transplant recipients with a diagnosis of dilated cardiomyopathy, primary pulmonary hypertension, or ischemic heart disease. The expression levels of each mRNA were compared with each other and then correlated with that of atrial natriuretic factor (ANF) mRNA in the failing ventricle. The mRNA levels for the calcium release channel (ryanodine receptor, RYR2), Ca2' uptake pump (Ca2+-ATPase, SERCA2 isoform), and phospholamban differed significantly between heart samples but showed an inverse relation with that of ventricular ANF mRNA. In contrast, calsequestrin mRNA levels remained unchanged in these failing hearts. In addition, f-myosin and a-cardiac actin mRNA levels also showed an inverse relation with ANF mRNA levels. These changes were observed in both right and left ventricles of hearts with congestive heart failure due to dilated cardiomyopathy, primary pulmonary hypertension, or ischemic heart disease. The results are consistent with the hypothesis that abnormal calcium handling in the sarcoplasmic reticulum of failing hearts is due to the altered expression of the genes encoding sarcoplasmic reticulum proteins. (Circulation Research 1993;72:463-469) KEY WoRDs * ryanodine receptor * phospholamban * calsequestrin * sarcoplasmic reticulum * Ca2'-ATPase H eart failure is a low cardiac output syndrome characterized by both systolic and diastolic dysfunction. The velocity and extent of ventricular contraction and the rate of pressure development are decreased in heart failure.1-3 The left ventricular (LV) relaxation rates, assessed by maximum rates of LV pressure decline, and the mean velocity of circumferential fiber length shortening in early diastole are also decreased, suggesting an impairment of early diastolic LV relaxation.4 The contraction and relaxation of cardiocytes are regulated by intracellular calcium (Ca'+) concentrations, which, in turn, are controlled
primarily by the release and reuptake of Ca`by the sarcoplasmic reticulum (SR). Accordingly, defects in Ca'+ release and Ca'+ uptake functions of the SR could result in the systolic and diastolic dysfunctions seen in heart failure.
In recent years, the major SR proteins controlling Ca'+ uptake, storage, and release have been isolated, and sequencing of complementary DNA (cDNA) encoding them has provided the deduced amino acid sequences. 5 The contraction of cardiac myocytes is triggered by Ca'+ release from the SR through a calcium release channel, also referred to as the ryanodine receptor (RYR).6 Two distinct isoforms of Ca'+ release channel (RYR) have been described by cDNA cloning,7-'0 but only the RYR2 isoform is expressed in cardiac tissues.'0" l Muscle relaxation is initiated by ATP-dependent transport of Ca 2 uptake into the SR.
Five distinct Ca'+-ATPase isoforms have been identified,5 the cardiac/slow-twitch isoform (SERCA2a) being the major Ca'2-ATPase expressed in cardiac tissue.1"-'3
The function of SERCA2a is inhibited by its interaction with a regulatory protein, phospholamban, but inhibition is relieved by both cyclic AMP (cAMP) and calmodulin-dependent phosphorylation of phospholamban. '4 Phospholamban is encoded by a single gene, and the same protein is expressed in cardiac and slow-twitch skeletal muscle tissues. 15 Calsequestrin, a high-capacity, fS-MHC and a-Actin mRNA Levels Also Showed an Inverse Relation to ANF mRNA Levels
We next examined whether expression levels of mRNAs for MUC and actin were also altered in heart failure using the same RNA samples (Figures 1 and 4) . The expression levels of mRNAs encoding f-MHC and a-cardiac actin were also modified and exhibited an inverse correlation with the ANF mRNA level (r between ANF mRNA and J3-MHC, -0.76,p<0.01; a-cardiac actin, -0.50, p<0.01) ( Figure 4 , Table 2 ). In contrast, the expression of a-skeletal actin mRNA remained high and did not show a correlation with ANF mRNA (r between ANF mRNA and a-skeletal actin, 0.04, NS) ( Figure 4 , Table 2 ). The expression of a-MHC mRNA was not detectable in any of the hearts examined.
Discussion
In this study, we report that the mRNA levels for the SR Ca2 release channel, Ca2+-ATPase, and phospholamban are drastically altered in hearts from patients with end-stage heart failure. In addition, MHC and a-cardiac actin mRNA were also altered in failing hearts. Because normal human hearts were difficult to C-RYR--r" t Ca-ATPase -* w i obtain, we were unable to determine the absolute decrease in mRNA levels in failing hearts, but a comparison was made between failing heart samples expressing different levels of ventricular ANF mRNA. More importantly, our measurements of the mRNAs for various Ca'4 transport proteins could be correlated with the abnormalities in Ca'4 release and uptake in the SR from failing hearts.
It has been shown that increases in circulating concentrations of ANF are associated with elevated cardiac filling pressure in the human failing heart34 and that plasma ANF concentration is increased in New York Heart Association (NYHA) functional classes II and III (moderate and severe) heart failure patients and is highest in NYHA class IV (severest) heart failure patients. 35 It has also been reported that the level of ventricular ANF mRNA expression is markedly increased in moderate heart failure and is highest in severe heart failure in the cardiomyopathic hamster model of congestive heart failure. 32, 36 In this study, we have also found the significant positive correlation between LV ANF mRNA level and LV end-diastolic pressure or pulmonary artery wedge pressure (r=0.72, p<0.05) in 10 patients for whom we could collect clinical data. Because the number of the patients examined and the hemodynamic parameters used were limited, whether ventricular ANF mRNA is directly proportional to the severity of heart failure remains to be determined. However, the analysis from this study and previous studies32-37 suggests that in general, ventricular ANF mRNA level would be higher in severe heart failure than in mild heart failure.
In this study, we have shown that the expression levels of mRNA for Ca24 release channel, Ca2+-ATPase, and phospholamban were inversely correlated with the ANF mRNA level, suggesting that the expression of these mRNAs was decreased in severe heart failure. Gwathmey et al19 and Morgan et a120 reported that muscle from failing human hearts exhibits' abnormal Ca2+ handling, manifested as prolonged Ca'4 transients, which indicates a diminished capacity to restore a low resting calcium level during diastole. Furthermore, tensionindependent heat measurements showed a substantial reduction in the amount of heat produced in muscle strips from the failing myocardium. Tension-independent heat is thought to result from the energy expended for Ca '4 transport Our analysis suggested that a-cardiac actin mRNA was decreased in severe heart failure, whereas a-skeletal actin mRNA maintained a high level of expression, as found in normal human myocardium (K. Schwartz, personal communication). Thus, a cardiac-to-skeletal isoform transition (as found in small mammals) is not seen for actin protein.
In conclusion, our studies on SR gene expression in human failing hearts suggest that a defect exists in the Ca2+ regulatory properties of the SR. Thus, abnormal calcium handling resulting from a decrease in the relative number of excitation-contraction coupling sites, which is suggested by the decrease of corresponding mRNA expression, could drastically modify the force-frequency relation and myocardial performance. These observations might have important implications for diagnosis and therapy of heart failure patients.
